Today, the George Institute for Global Health announced that it had reached
a purchase agreement with the international investment firm Hillhouse to
sell its clinical research arm, George Clinical (CRO).
a purchase agreement with the international investment firm Hillhouse to
sell its clinical research arm, George Clinical (CRO).
Hillhouse is well-versed in the healthcare industry and has partnered with,
supported, and expanded healthcare companies worldwide. George Clinical
will get substantial fresh funding to aid in its continued path of rapid
worldwide expansion and strengthen its position as the market leader in the
Asia-Pacific as a result of this deal.
